MedSwitcher
All Articles
Cost & Insurance

Wegovy Pill Cost in 2026: Insurance, Savings Card & How to Pay Less

April 12, 20268 min readMedSwitcher Editorial Team

The FDA-approved oral Wegovy (semaglutide 25 mg tablet) gives patients a needle-free path to clinically significant weight loss — but the first question most people ask is: how much does the Wegovy pill cost? The answer depends on your insurance, pharmacy, and whether you qualify for savings programs. This guide breaks down every pricing option available in 2026, including the Novo Nordisk savings card, Medicare GLP-1 Bridge, GoodRx coupons, and tips for getting insurance prior authorization approved.

Self-Pay Pricing Without Insurance

Without any insurance or discount programs, the list price for oral Wegovy varies by dose:

  • 1.5 mg (starting dose): ~$149/month via NovoCare direct or GoodRx
  • 4 mg: ~$169–$189/month
  • 9 mg: ~$199–$219/month
  • 25 mg (maintenance dose): ~$229–$249/month

These prices reflect retail pharmacy pricing as of April 2026 and may vary by location. Specialty pharmacies and mail-order services sometimes offer lower rates for 90-day supplies.

Novo Nordisk Savings Card

Novo Nordisk offers a manufacturer savings card for patients with commercial (private) insurance coverage. The program reduces your monthly out-of-pocket cost to as low as $25/month for eligible patients. Key details:

  • Available to patients with commercial insurance that covers Wegovy
  • Maximum savings of up to $500 per 28-day supply
  • Cannot be combined with government insurance (Medicare, Medicaid, Tricare)
  • Enrollment is free through NovoCare.com or by calling 1-888-693-8946
  • The card auto-renews annually and can be used at most retail pharmacies

If your commercial insurance covers Wegovy but leaves you with a high copay ($100–$300/month), the savings card can bring your cost down to $25–$50/month — making it one of the most effective cost-reduction tools available.

Medicare Coverage: GLP-1 Bridge Program (July 2026)

Beginning July 1, 2026, Medicare will cover oral Wegovy under the new GLP-1 Bridge program. This is a major milestone — until now, Medicare explicitly excluded coverage for weight-loss medications. Under the Bridge program:

  • Expected patient cost: approximately $50/month (after Part D coverage)
  • Prior authorization required with documented BMI ≥30 or ≥27 with comorbidity
  • Coverage includes both oral and injectable Wegovy formulations
  • The program is part of a broader CMS initiative to reduce obesity-related healthcare costs

If you are a Medicare beneficiary interested in Wegovy, contact your Part D plan now to understand formulary placement and any step therapy requirements. Read more in our GLP-1 Medicare coverage guide.

GoodRx and Pharmacy Discount Coupons

For patients without insurance or with plans that do not cover Wegovy, GoodRx coupons can reduce out-of-pocket costs by 10–30%. Prices vary by pharmacy — Costco, Walmart, and Amazon Pharmacy tend to offer the lowest rates. Always compare prices across multiple pharmacies before filling your prescription.

Amazon Pharmacy Availability

Amazon Pharmacy now carries oral Wegovy and offers competitive pricing with free delivery for Prime members. Amazon also supports manufacturer savings cards and insurance billing, making it a convenient option for monthly refills. Prime members may also access additional discounts on select generic alternatives when available.

Cost Comparison: Wegovy Pill vs Injectable vs Foundayo

Medication Self-Pay (Monthly) With Savings Card Medicare (Jul 2026+)
Wegovy Pill (Oral) $149–$249 $25–$50 ~$50
Wegovy Injectable $130–$220 $25–$45 ~$50
Foundayo (Oral) $149–$349 $30–$60 ~$55

5 Tips to Get Insurance Prior Authorization Approved

Most commercial insurers and Medicare Part D plans require prior authorization (PA) before covering Wegovy. Use these strategies to improve your chances of first-pass approval:

  • 1. Document BMI and comorbidities: Ensure your chart includes a BMI ≥30 (or ≥27 with at least one weight-related condition such as hypertension, type 2 diabetes, dyslipidemia, or sleep apnea).
  • 2. Include a physician letter of medical necessity: Your provider should explain why lifestyle modifications alone have been insufficient and why Wegovy is clinically appropriate.
  • 3. Submit a 6–12 month weight history: Many insurers want to see documented evidence of prior weight-loss attempts, including diet and exercise programs.
  • 4. Use NovoCare's prior authorization support: Novo Nordisk offers free PA assistance tools and pre-filled forms through their NovoCare portal — this significantly reduces administrative burden on your provider.
  • 5. Appeal if denied: Roughly 40–50% of initial PA denials are overturned on appeal. Request a peer-to-peer review between your physician and the insurer's medical director, and include updated clinical data.

Oral GLP-1 tablets now available — from $99/mo

Compare oral GLP-1 options including Wegovy pills and Foundayo. MEDVi offers tablets alongside injectables — a provider helps you choose.

See Oral GLP-1 Options →

Medical Disclaimer

Costs, coverage, and savings programs are subject to change and may vary by location, pharmacy, and insurer. This information is for educational purposes only and does not constitute financial or medical advice. Always verify coverage details with your insurance provider and consult your healthcare provider to determine the best treatment option for your health and financial situation.

Get GLP-1 Price Drop Alerts

Join 500+ patients tracking medication prices and availability

Get Free Alerts →

Medical Disclaimer

This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read on this website.